Biosimilar Newsletter Archive
-
11.05.26 -- 7 Decisions To Make Before MES Configuration
11/5/2026
11/05/26 Biosimilar Development Newsletter
-
10.29.26 -- How Indian Biosimilar Companies Are Poised To Succeed
10/29/2026
10/29/26 Biosimilar Development Newsletter
-
10.27.26 -- Reduce Bioprocessing Supply Risk With Manufacturing Closer To You
10/27/2026
10/27/26 Biosimilar Development Newsletter
-
10.22.26 -- Reduce risk. Move Annex 1 forward.
10/22/2026
10/22/26 Biosimilar Development Newsletter
-
10.22.26 -- FDA Modernizes Container Closure Guidance: What Is Changing
10/22/2026
10/22/26 Biosimilar Development Newsletter
-
10.21.26 -- A Sustainable Future: Leveraging 3Rs To Innovate And Accelerate In Testing
10/21/2026
10/21/26 Biosimilar Development Newsletter
-
10.20.26 -- Reduce risk. Move Annex 1 forward.
10/20/2026
10/20/26 Bioprocess Online Newsletter
-
10.15.26 -- You Can't CAPA What You Can't Classify
10/15/2026
10/15/26 Biosimilar Development Newsletter
-
10.08.26 -- Building Trust In AI For Computerized System Validation
10/8/2026
10/08/26
-
10.01.26 -- Faster Paths To Biosimilar Equivalence
10/1/2026
10/01/26 Biosimilar Development Newsletter